Clinical trials tech is a rapidly growing sector of digital health. It addresses the rising demand to make clinical trials faster, cheaper, and more patient-centric.
To do this, new tech-enabled solutions are targeting key bottlenecks throughout the clinical trial lifecycle for all participating stakeholders, from researchers to life science companies to patients.
To help strategy teams prioritize clinical trials markets in their planning decisions, we plotted markets using CB Insights’ TECH framework, which scores markets across 2 dimensions:
